<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">phkinetica</journal-id><journal-title-group><journal-title xml:lang="ru">Фармакокинетика и Фармакодинамика</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacokinetics and Pharmacodynamics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7836</issn><issn pub-type="epub">2686-8830</issn><publisher><publisher-name>ООО «Издательство ОКИ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2587-7836-2023-4-15-22</article-id><article-id custom-type="elpub" pub-id-type="custom">phkinetica-388</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИССЛЕДОВАНИЯ ФАРМАКОДИНАМИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACODYNAMICS STUDIES</subject></subj-group></article-categories><title-group><article-title>Пептиды плаценты: антибактериальные эффекты</article-title><trans-title-group xml:lang="en"><trans-title>Placenta peptides: antibacterial effects</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2659-7998</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торшин</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Torshin</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Торшин Иван Юрьевич - к. ф–м. н., к. х. н., в. н. с. </p><p>Москва </p></bio><bio xml:lang="en"><p> </p><p>Moscow </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5042-4886</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богачева</surname><given-names>Т. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogacheva</surname><given-names>T. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Богачева Татьяна Евгеньевна - к. м. н., доцент кафедры фармакологии  </p><p>Иваново </p></bio><bio xml:lang="en"><p> </p><p>Ivanovo </p></bio><email xlink:type="simple">tatiana.boga4iova@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7663-710X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Громова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gromova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Громова Ольга Алексеевна - д. м. н, профессор, в. н. с. </p><p>Москва </p></bio><bio xml:lang="en"><p> </p><p>Moscow </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГУ «Федеральный исследовательский центр «Информатика и управление» РАН» (ФИЦ ИУ РАН)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FRC "Computer Science and Control" RAS</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ивановская государственная медицинская академия» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBEI HE "Ivanovo State Medical Academy" MOH Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>22</day><month>01</month><year>2024</year></pub-date><volume>0</volume><issue>4</issue><fpage>15</fpage><lpage>22</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Торшин И.Ю., Богачева Т.Е., Громова О.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Торшин И.Ю., Богачева Т.Е., Громова О.А.</copyright-holder><copyright-holder xml:lang="en">Torshin I.Y., Bogacheva T.E., Gromova O.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacokinetica.ru/jour/article/view/388">https://www.pharmacokinetica.ru/jour/article/view/388</self-uri><abstract><p>Масс-спектрометрическое секвенирование пептидов в составе Лаеннека указало на наличие в составе препарата 5 пептидов, биологическая активность которых может обуславливать антибактериальные свойства препарата. Наиболее значимым результатом настоящего исследования является нахождение в составе Лаеннека фрагмента антибактериального пептида кателицидина (LL-37), важного витамин-D-зависимого фактора врождённого иммунитета. Другие пептиды Лаеннека способствуют снижению избыточного воспаления посредством ингибирования активности белка NF-kB, опосредующего эффекты ФНО-α.</p></abstract><trans-abstract xml:lang="en"><p>Mass spectrometric sequencing of peptides in Laennec indicated the presence of 5 peptides in the drug, the biological activity of which may determine the antibacterial properties of the drug. The most significant result of this study is the presence in Laennec of a fragment of the antibacterial peptide cathelicidin (LL-37), an important vitamin D-dependent factor of innate immunity. Other Laennec peptides help reduce excess inflammation by inhibiting the activity of the NF-kB protein, which mediates the effects of TNF-α.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гидролизаты плаценты</kwd><kwd>антибактериальный эффект</kwd></kwd-group><kwd-group xml:lang="en"><kwd>placenta hydrolysates</kwd><kwd>antibacterial effect</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О., Торшин И., Гилельс А., и др. Препараты плаценты человека: фундаментальные и клинические исследования. Врач. 2014;(4):67-72. Gromova O, Torshin I, Gilels A, et al. Human placental preparations: basic and clinical studies. Vrach (The Doctor). 2014;(4):67–72. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Громова О., Торшин И., Гилельс А., и др. Препараты плаценты человека: фундаментальные и клинические исследования. Врач. 2014;(4):67-72. Gromova O, Torshin I, Gilels A, et al. Human placental preparations: basic and clinical studies. Vrach (The Doctor). 2014;(4):67–72. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Shukla VK, Rasheed MA, Kumar M, et al. A trial to determine the role of placental extract in the treatment of chronic non-healing wounds. J Wound Care. 2004 May;13(5):177–179. DOI: 10.12968/jowc.2004.13.5.26668.</mixed-citation><mixed-citation xml:lang="en">Shukla VK, Rasheed MA, Kumar M, et al. A trial to determine the role of placental extract in the treatment of chronic non-healing wounds. J Wound Care. 2004 May;13(5):177–179. DOI: 10.12968/jowc.2004.13.5.26668.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И., Волков А., Гилельс А., и др. Пептидный состав препарата плаценты человека лаеннек и молекулярные механизмы его воздействия на организм человека. Эстетическая медицина. 2013;XII(1):33–-45. Torshin I, Volkov A, Gilels A, et al. Peptide composition of the human placenta drug Laennec and the molecular mechanisms of its effect on the human body. Aesthetic medicine. 2013;XII(1):33–45. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Торшин И., Волков А., Гилельс А., и др. Пептидный состав препарата плаценты человека лаеннек и молекулярные механизмы его воздействия на организм человека. Эстетическая медицина. 2013;XII(1):33–-45. Torshin I, Volkov A, Gilels A, et al. Peptide composition of the human placenta drug Laennec and the molecular mechanisms of its effect on the human body. Aesthetic medicine. 2013;XII(1):33–45. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Caruselli M, Tigano F. Azione degli estratti di placenta alla Filatov su alcuni fenomeni immunitari [Effect of Filatov's placental extracts on some immunization phenomena]. G Batteriol Immunol. 1953 Sep-Oct;46(1-2):15–23. Undetermined Language.</mixed-citation><mixed-citation xml:lang="en">Caruselli M, Tigano F. Azione degli estratti di placenta alla Filatov su alcuni fenomeni immunitari [Effect of Filatov's placental extracts on some immunization phenomena]. G Batteriol Immunol. 1953 Sep-Oct;46(1-2):15–23. Undetermined Language.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kludas M, Knoblauch R. Plazentaextrakt bei Psoriasis [Therapy of psoriasis with placental extract]. Med Klin. 1952 Oct 31;47(44):1459–1461. Undetermined Language</mixed-citation><mixed-citation xml:lang="en">Kludas M, Knoblauch R. Plazentaextrakt bei Psoriasis [Therapy of psoriasis with placental extract]. Med Klin. 1952 Oct 31;47(44):1459–1461. Undetermined Language</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Novikova ZI. Vliianie vzvesi platsenty na immunologicheskie pokazateli i dinamiku kozhnogo protsessa u bol'nykh ladonno-podoshvennym pustuleznym psoriazom [Effect of placenta suspension on the immunologic indicators and dynamics of skin changes in patients with palmar and plantar pustulous psoriasis]. Vestn Dermatol Venerol. 1985 Oct;(10):46–48. Russian.</mixed-citation><mixed-citation xml:lang="en">Novikova ZI. Vliianie vzvesi platsenty na immunologicheskie pokazateli i dinamiku kozhnogo protsessa u bol'nykh ladonno-podoshvennym pustuleznym psoriazom [Effect of placenta suspension on the immunologic indicators and dynamics of skin changes in patients with palmar and plantar pustulous psoriasis]. Vestn Dermatol Venerol. 1985 Oct;(10):46–48. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Trebula J. Liecba roztrúsenej mozgomiechovej sklerózy extratom placenty [Therapy of multiple sclerosis with placental extracts]. Bratisl Lek Listy. 1952;32(5-6):313–323. Undetermined Language.</mixed-citation><mixed-citation xml:lang="en">Trebula J. Liecba roztrúsenej mozgomiechovej sklerózy extratom placenty [Therapy of multiple sclerosis with placental extracts]. Bratisl Lek Listy. 1952;32(5-6):313–323. Undetermined Language.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dillon RN, Majnarich JJ. Placental extract in treatment of rheumatoid arthritis. Northwest Med. 1951 September; 50(9):677–679.</mixed-citation><mixed-citation xml:lang="en">Dillon RN, Majnarich JJ. Placental extract in treatment of rheumatoid arthritis. Northwest Med. 1951 September; 50(9):677–679.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin IYu, Rudakov KV. On metric spaces arising during formalization of problems of recognition and classification. Part 2: Density properties. Pattern Recognition and Image Analysis. Advances in Mathematical Theory and Applications. 2016;26(3):483–496.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Rudakov KV. On metric spaces arising during formalization of problems of recognition and classification. Part 2: Density properties. Pattern Recognition and Image Analysis. Advances in Mathematical Theory and Applications. 2016;26(3):483–496.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Згода В.Г., Громова О.А., и др. Анализ лёгкой пептидной фракции Лаеннека методами современной протеомики. Фармакокинетика и Фармакодинамика. 2016;(4):31–42. Torshin IYu, Zgoda VG, Gromova OA, et al. Analysis of the light peptide fraction of Laennec by proteomic methods. Pharmacokinetics and Pharmacodynamics. 2016;(4):31–42. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Торшин И.Ю., Згода В.Г., Громова О.А., и др. Анализ лёгкой пептидной фракции Лаеннека методами современной протеомики. Фармакокинетика и Фармакодинамика. 2016;(4):31–42. Torshin IYu, Zgoda VG, Gromova OA, et al. Analysis of the light peptide fraction of Laennec by proteomic methods. Pharmacokinetics and Pharmacodynamics. 2016;(4):31–42. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Agerberth B, Gunne H, Odeberg J, et al. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):195–199. DOI: 10.1073/pnas.92.1.195.</mixed-citation><mixed-citation xml:lang="en">Agerberth B, Gunne H, Odeberg J, et al. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):195–199. DOI: 10.1073/pnas.92.1.195.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gudmundsson GH, Agerberth B, Odeberg J, et al. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem. 1996 Jun 1;238(2):325–332. DOI: 10.1111/j.1432-1033.1996.0325z.x.</mixed-citation><mixed-citation xml:lang="en">Gudmundsson GH, Agerberth B, Odeberg J, et al. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem. 1996 Jun 1;238(2):325–332. DOI: 10.1111/j.1432-1033.1996.0325z.x.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nabel GJ, Verma IM. Proposed NF-kappa B/I kappa B family nomenclature. Genes Dev. 1993 Nov;7(11):2063. DOI: 10.1101/gad.7.11.2063.</mixed-citation><mixed-citation xml:lang="en">Nabel GJ, Verma IM. Proposed NF-kappa B/I kappa B family nomenclature. Genes Dev. 1993 Nov;7(11):2063. DOI: 10.1101/gad.7.11.2063.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986 Aug 29;46(5):705–716. DOI: 10.1016/0092-8674(86)90346-6.</mixed-citation><mixed-citation xml:lang="en">Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986 Aug 29;46(5):705–716. DOI: 10.1016/0092-8674(86)90346-6.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Llona-Minguez S, Baiget J, Mackay SP. Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases. Pharm Pat Anal. 2013 Jul;2(4):481–498. DOI: 10.4155/ppa.13.31.</mixed-citation><mixed-citation xml:lang="en">Llona-Minguez S, Baiget J, Mackay SP. Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases. Pharm Pat Anal. 2013 Jul;2(4):481–498. DOI: 10.4155/ppa.13.31.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Carter RS, Pennington KN, Ungurait BJ, Ballard DW. In vivo identification of inducible phosphoacceptors in the IKKgamma/NEMO subunit of human IkappaB kinase. J Biol Chem. 2003 May 30;278(22):19642– 19648. DOI: 10.1074/jbc.M301705200.</mixed-citation><mixed-citation xml:lang="en">Carter RS, Pennington KN, Ungurait BJ, Ballard DW. In vivo identification of inducible phosphoacceptors in the IKKgamma/NEMO subunit of human IkappaB kinase. J Biol Chem. 2003 May 30;278(22):19642– 19648. DOI: 10.1074/jbc.M301705200.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Frohm M, Gunne H, Bergman AC, et al. Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem. 1996 Apr 1;237(1):86–92. DOI: 10.1111/j.1432-1033.1996.0086n.x.</mixed-citation><mixed-citation xml:lang="en">Frohm M, Gunne H, Bergman AC, et al. Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem. 1996 Apr 1;237(1):86–92. DOI: 10.1111/j.1432-1033.1996.0086n.x.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Marcinkiewicz M, Majewski S. The role of antimicrobial peptides in chronic inflammatory skin diseases. Postepy Dermatol Alergol. 2016 Feb;33(1): 6–12. DOI: 10.5114/pdia.2015.48066.</mixed-citation><mixed-citation xml:lang="en">Marcinkiewicz M, Majewski S. The role of antimicrobial peptides in chronic inflammatory skin diseases. Postepy Dermatol Alergol. 2016 Feb;33(1): 6–12. DOI: 10.5114/pdia.2015.48066.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ребров В.Г., Громова О.А. Витамины, макро- и микроэлементы. ГэотарМед, 2008, 986 с. Rebrov VG, Gromova OA. Vitamins, macro- and microelements. GeoTarMed, 2008. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Ребров В.Г., Громова О.А. Витамины, макро- и микроэлементы. ГэотарМед, 2008, 986 с. Rebrov VG, Gromova OA. Vitamins, macro- and microelements. GeoTarMed, 2008. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Громова О.А., Диброва Е.А., и др. Пептиды в составе препарата Лаеннек, потенцирующие его антивирусные эффекты. Российский Аллергологический Журнал. 2018;6–2017:82–90. Torshin IYu, Gromova OA, Dibrova EA, et al. Peptides in the composition of Laennec that show antiviral effects in the therapy of atopic dermatitis and herpes infection. Russian Allergological Journal. 2018;6–2017:82–90. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Торшин И.Ю., Громова О.А., Диброва Е.А., и др. Пептиды в составе препарата Лаеннек, потенцирующие его антивирусные эффекты. Российский Аллергологический Журнал. 2018;6–2017:82–90. Torshin IYu, Gromova OA, Dibrova EA, et al. Peptides in the composition of Laennec that show antiviral effects in the therapy of atopic dermatitis and herpes infection. Russian Allergological Journal. 2018;6–2017:82–90. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Nakagawa Y, Gallo RL. Endogenous intracellular cathelicidin enhances TLR9 activation in dendritic cells and macrophages. J Immunol. 2015 Feb 1; 194(3):1274–1284. DOI: 10.4049/jimmunol.1402388.</mixed-citation><mixed-citation xml:lang="en">Nakagawa Y, Gallo RL. Endogenous intracellular cathelicidin enhances TLR9 activation in dendritic cells and macrophages. J Immunol. 2015 Feb 1; 194(3):1274–1284. DOI: 10.4049/jimmunol.1402388.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin IYu, Rudakov KV. Combinatorial analysis of the solvability properties of the problems of recognition and completeness of algorithmic models. part 2: metric approach within the framework of the theory of classification of feature values. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2017;27(2):184–199.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Rudakov KV. Combinatorial analysis of the solvability properties of the problems of recognition and completeness of algorithmic models. part 2: metric approach within the framework of the theory of classification of feature values. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2017;27(2):184–199.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Korucu E, Pur Ozyigit L, Ortakoylu MG, et al. Cathelicidin as a link between sarcoidosis and tuberculosis. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Sep 14;32(3):222–227.</mixed-citation><mixed-citation xml:lang="en">Korucu E, Pur Ozyigit L, Ortakoylu MG, et al. Cathelicidin as a link between sarcoidosis and tuberculosis. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Sep 14;32(3):222–227.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Jeng L, Yamshchikov AV, Judd SE, et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med. 2009 Apr 23;7:28. DOI: 10.1186/1479-5876-7-28.</mixed-citation><mixed-citation xml:lang="en">Jeng L, Yamshchikov AV, Judd SE, et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med. 2009 Apr 23;7:28. DOI: 10.1186/1479-5876-7-28.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Лиманова О.А., Торшин И.Ю., Сардарян И.С., и др. Обеспеченность микронутриентами и женское здоровье: интеллектуальный анализ клинико-эпидемиологических данных. Вопросы гинекологии, акушерства и перинатологии. 2014;13(2):5–15. Limanova OA, Torshin IYu, Sardaryan IS, et al. Micronutrient provision and women's health: intellectual analysis of clinical and epidemiological data. Issues of gynecology, obstetrics and perinatology. 2014;13(2):5–15. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Лиманова О.А., Торшин И.Ю., Сардарян И.С., и др. Обеспеченность микронутриентами и женское здоровье: интеллектуальный анализ клинико-эпидемиологических данных. Вопросы гинекологии, акушерства и перинатологии. 2014;13(2):5–15. Limanova OA, Torshin IYu, Sardaryan IS, et al. Micronutrient provision and women's health: intellectual analysis of clinical and epidemiological data. Issues of gynecology, obstetrics and perinatology. 2014;13(2):5–15. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Лиманова О.А., Сардарян И.С., и др. Обеспеченность витамином D детей и подростков 7-14 лет и взаимосвязь дефицита витамина D с нарушениями здоровья детей: анализ крупномасштабной выборки пациентов посредством интеллектуального анализа данных. Педиатрия. Журнал им. Г.Н. Сперанского. 2015;94(2):175–184. Torshin IYu, Limanova OA, Sardaryan IS, et al. Provision of vitamin d in children and adolescents aged 7 to 14 years and the relationship of deficiency of vitamin d with violations of children’s health: the analysis of a large-scale sample of patients by means of data mining. Journal named after G.N. Speransky. 2015;94(2):175–184. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Торшин И.Ю., Лиманова О.А., Сардарян И.С., и др. Обеспеченность витамином D детей и подростков 7-14 лет и взаимосвязь дефицита витамина D с нарушениями здоровья детей: анализ крупномасштабной выборки пациентов посредством интеллектуального анализа данных. Педиатрия. Журнал им. Г.Н. Сперанского. 2015;94(2):175–184. Torshin IYu, Limanova OA, Sardaryan IS, et al. Provision of vitamin d in children and adolescents aged 7 to 14 years and the relationship of deficiency of vitamin d with violations of children’s health: the analysis of a large-scale sample of patients by means of data mining. Journal named after G.N. Speransky. 2015;94(2):175–184. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Thomi R, Schlapbach C, Yawalkar N, et al. Elevated levels of the antimicrobial peptide LL-37 in hidradenitis suppurativa are associated with a Th1/Th17 immune response. Exp Dermatol. 2018 Feb;27(2):172–177. DOI: 10.1111/exd.13482.</mixed-citation><mixed-citation xml:lang="en">Thomi R, Schlapbach C, Yawalkar N, et al. Elevated levels of the antimicrobial peptide LL-37 in hidradenitis suppurativa are associated with a Th1/Th17 immune response. Exp Dermatol. 2018 Feb;27(2):172–177. DOI: 10.1111/exd.13482.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Sun W, Zheng Y, Lu Z, et al. LL-37 attenuates inflammatory impairment via mTOR signaling-dependent mitochondrial protection. Int J Biochem Cell Biol. 2014 Sep;54:26–35. DOI: 10.1016/j.biocel.2014.06.015.</mixed-citation><mixed-citation xml:lang="en">Sun W, Zheng Y, Lu Z, et al. LL-37 attenuates inflammatory impairment via mTOR signaling-dependent mitochondrial protection. Int J Biochem Cell Biol. 2014 Sep;54:26–35. DOI: 10.1016/j.biocel.2014.06.015.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Takiguchi T, Morizane S, Yamamoto T, et al. Antimicrobial cathelicidin peptide LL-37 enhances interferon-β expression and antiviral activity induced by double-stranded RNA in keratinocytes. Br J Dermatol. 2014 September; 171(3):492–498. DOI: 10.1111/BJD.12942.</mixed-citation><mixed-citation xml:lang="en">Takiguchi T, Morizane S, Yamamoto T, et al. Antimicrobial cathelicidin peptide LL-37 enhances interferon-β expression and antiviral activity induced by double-stranded RNA in keratinocytes. Br J Dermatol. 2014 September; 171(3):492–498. DOI: 10.1111/BJD.12942.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Pinheiro da Silva F, Machado MC. The dual role of cathelicidins in systemic inflammation. Immunol Lett. 2017 Feb;182:57–60. DOI: 10.1016/j.imlet.2017.01.004.</mixed-citation><mixed-citation xml:lang="en">Pinheiro da Silva F, Machado MC. The dual role of cathelicidins in systemic inflammation. Immunol Lett. 2017 Feb;182:57–60. DOI: 10.1016/j.imlet.2017.01.004.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Das S, Sardar AH, Abhishek K, et al. Cathelicidin augments VDRdependent anti-leishmanial immune response in Indian Post-Kala-Azar Dermal Leishmaniasis. Int Immunopharmacol. 2017 Sep;50:130–138. DOI: 10.1016/j.intimp.2017.06.010.</mixed-citation><mixed-citation xml:lang="en">Das S, Sardar AH, Abhishek K, et al. Cathelicidin augments VDRdependent anti-leishmanial immune response in Indian Post-Kala-Azar Dermal Leishmaniasis. Int Immunopharmacol. 2017 Sep;50:130–138. DOI: 10.1016/j.intimp.2017.06.010.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Fuentes-Duculan J, Bonifacio KM, Hawkes JE, Kunjravia N, Cueto I, Li X, Gonzalez J, Garcet S, Krueger JG. Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes. Exp Dermatol. 2017 Nov;26(11):1075–1082. DOI: 10.1111/exd.13378</mixed-citation><mixed-citation xml:lang="en">Fuentes-Duculan J, Bonifacio KM, Hawkes JE, Kunjravia N, Cueto I, Li X, Gonzalez J, Garcet S, Krueger JG. Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes. Exp Dermatol. 2017 Nov;26(11):1075–1082. DOI: 10.1111/exd.13378</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss E, Katta R. Diet and rosacea: the role of dietary change in the management of rosacea. Dermatol Pract Concept. 2017 Oct 31;7(4):31—37. DOI: 10.5826/dpc.0704a08.</mixed-citation><mixed-citation xml:lang="en">Weiss E, Katta R. Diet and rosacea: the role of dietary change in the management of rosacea. Dermatol Pract Concept. 2017 Oct 31;7(4):31—37. DOI: 10.5826/dpc.0704a08.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Wang WM, Jin HZ. Skin Microbiome: An Actor in the Pathogenesis of Psoriasis. Chin Med J (Engl). 2018 Jan 5;131(1):95–98. DOI: 10.4103/0366-6999.221269.</mixed-citation><mixed-citation xml:lang="en">Wang WM, Jin HZ. Skin Microbiome: An Actor in the Pathogenesis of Psoriasis. Chin Med J (Engl). 2018 Jan 5;131(1):95–98. DOI: 10.4103/0366-6999.221269.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L, Wu WK, Gallo RL, et al. Critical Role of Antimicrobial Peptide Cathelicidin for Controlling Helicobacter pylori Survival and Infection. J Immunol. 2016 Feb 15;196(4):1799–1809. DOI: 10.4049/jimmunol.1500021.</mixed-citation><mixed-citation xml:lang="en">Zhang L, Wu WK, Gallo RL, et al. Critical Role of Antimicrobial Peptide Cathelicidin for Controlling Helicobacter pylori Survival and Infection. J Immunol. 2016 Feb 15;196(4):1799–1809. DOI: 10.4049/jimmunol.1500021.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Muto Y, Wang Z, Vanderberghe M, et al. Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea. J Invest Dermatol. 2014 Nov;134(11):2728–2736. DOI: 10.1038/jid.2014.222.</mixed-citation><mixed-citation xml:lang="en">Muto Y, Wang Z, Vanderberghe M, et al. Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea. J Invest Dermatol. 2014 Nov;134(11):2728–2736. DOI: 10.1038/jid.2014.222.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X, Takai T, Xie Y, et al. Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes. Biochem Biophys Res Commun. 2013 Apr 19;433(4):532–537. DOI: 10.1016/j.bbrc.2013.03.024.</mixed-citation><mixed-citation xml:lang="en">Chen X, Takai T, Xie Y, et al. Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes. Biochem Biophys Res Commun. 2013 Apr 19;433(4):532–537. DOI: 10.1016/j.bbrc.2013.03.024.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang YY, Yu YY, Zhang YR, et al. The modulatory effect of TLR2 on LL-37-induced human mast cells activation. Biochem Biophys Res Commun. 2016 Feb 5;470(2):368–374. DOI: 10.1016/j.bbrc.2016.01.037.</mixed-citation><mixed-citation xml:lang="en">Zhang YY, Yu YY, Zhang YR, et al. The modulatory effect of TLR2 on LL-37-induced human mast cells activation. Biochem Biophys Res Commun. 2016 Feb 5;470(2):368–374. DOI: 10.1016/j.bbrc.2016.01.037.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
